Android Apple

Forecast: Analysts Think Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Business Prospects Have Improved Drastically

By Yahoo! Finance   |   4 months ago
Forecast: Analysts Think Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Business Prospects Have Improved Drastically

Analysts have significantly upgraded revenue estimates for Entrada Therapeutics (NASDAQ:TRDA), leading to a surge in stock price. Despite concerns of revenue decline in 2024, the company is expected to turn profitable this year.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.